Clinical significance of the transcription factor (SOX11) expression in the bone marrow of acute myeloid leukemia patients

doi:10.5306/wjco.v16.i6.107271

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-2)

Sum=0

Jun 24, 2025 (publication date) through Jun 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Jun 24, 2025; 16(6): 107271
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107271

Open in New Tab Full Size Figure Download Figure

Figure 1 Disease-free survival and overall survival in acute myeloid leukemia patients in relation to SOX11 gene expression. A: Disease-free survival; B: Overall survival.

Citation: Abdel Aziz RS, Radwan EM, Fouad AM, Abdellateif MS, Elfishawi S. Clinical significance of the transcription factor (SOX11) expression in the bone marrow of acute myeloid leukemia patients. World J Clin Oncol 2025; 16(6): 107271
URL: https://www.wjgnet.com/2218-4333/full/v16/i6/107271.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i6.107271